Fortis Healthcare: To Buy 26% Stake In Clean Max Sau Private Limited For ₹1.85 Crore, Focused On Enhancing Solar Power Production In Haryana

 12 Oct 2026 03:58 PM

Fortis Healthcare: To Buy 26% Stake In Clean Max Sau Private Limited For ₹1.85 Crore, Focused On Enhancing Solar Power Production In Haryana

IHH Healthcare Bhd Will Work Fully With Forensic Audit, Believing That An Independent Review Will Clearly Determine The Facts On Transactions; IHH Was Not Involved In The Dispute Or Proceedings Between Daiichi Sankyo And Its Judgment Debtors (Fortis Healthcare.)

 28 Sep 2026 03:15 PM

IHH Healthcare Bhd Will Work Fully With Forensic Audit, Believing That An Independent Review Will Clearly Determine The Facts On Transactions; IHH Was Not Involved In The Dispute Or Proceedings Between Daiichi Sankyo And Its Judgment Debtors (Fortis Healthcare.)

IHHHealthcare BHD- Supreme Court Of India On Sept 25 Disposed Of Special Leave Petition Filed By Fortis (Fortis Healthcare)

 28 Sep 2026 03:13 PM

IHHHealthcare BHD- Supreme Court Of India On Sept 25 Disposed Of Special Leave Petition Filed By Fortis (Fortis Healthcare)

Fortis Healthcare Ltd: NTK Appeals Tokyo Court Ruling In Daiichi Sankyo Case Submitted To Tokyo High Court On September 24, 2026.

 25 Sep 2026 01:42 PM

Fortis Healthcare Ltd: NTK Appeals Tokyo Court Ruling In Daiichi Sankyo Case Submitted To Tokyo High Court On September 24, 2026.

Fortis Healthcare: Company Signs Agreement For New 400+ Bed Super Specialty Hospital In Ashok Vihar, Delhi

 16 Sep 2026 07:07 PM

Fortis Healthcare: Company Signs Agreement For New 400+ Bed Super Specialty Hospital In Ashok Vihar, Delhi

Fortis Healthcare: Co. Files Special Leave Petition Before SC Against Delhi HC Judgment Dated August 31, 2026; Case Involves Daiichi Sankyo Company And Malvinder Mohan Singh.

 16 Sep 2026 11:03 AM

Fortis Healthcare: Co. Files Special Leave Petition Before SC Against Delhi HC Judgment Dated August 31, 2026; Case Involves Daiichi Sankyo Company And Malvinder Mohan Singh.

Fortis Healthcare: To Hold Analyst And Investor Meeting On September 21 At 9 AM

 15 Sep 2026 08:32 PM

Fortis Healthcare: To Hold Analyst And Investor Meeting On September 21 At 9 AM

Fortis Healthcare: Tokyo District Court Dismisses NTK's Claim Against Daiichi Sankyo; NTK Must Cover Legal Fees and Plans to Review the Decision for Further Action.

 11 Sep 2026 12:49 PM

Fortis Healthcare: Tokyo District Court Dismisses NTK's Claim Against Daiichi Sankyo; NTK Must Cover Legal Fees and Plans to Review the Decision for Further Action.

Fortis Healthcare Limited: Ntk's Claim Against Daiichi Sankyo Dismissed By Tokyo District Court; Ntk To Bear Litigation Costs; Ntk Plans To Review Judgment And Pursue Legal Remedies.

 11 Sep 2026 12:55 PM

Fortis Healthcare Limited: Ntk's Claim Against Daiichi Sankyo Dismissed By Tokyo District Court; Ntk To Bear Litigation Costs; Ntk Plans To Review Judgment And Pursue Legal Remedies.

Fortis Healthcare: Company To Hold Analyst And Investor Meeting On September 14 And 15 At 8 AM

 09 Sep 2026 08:35 PM

Fortis Healthcare: Company To Hold Analyst And Investor Meeting On September 14 And 15 At 8 AM

Fortis Healthcare: HSBC on Fortis Healthcare Buy, Target Price ₹1,100, as the Delhi HC-ordered forensic audit is not expected to affect operations or IHH’s plan to raise its stake, with audit updates the key monitorable.

 07 Sep 2026 08:51 AM

Fortis Healthcare: HSBC on Fortis Healthcare Buy, Target Price ₹1,100, as the Delhi HC-ordered forensic audit is not expected to affect operations or IHH’s plan to raise its stake, with audit updates the key monitorable.

Fortis Healthcare: Jefferies on Fortis Healthcare Buy, Target Price ₹1,125, as the forensic audit is unlikely to disrupt operations or expansion, IHH remains committed to Fortis as its India growth platform, and any audit-led weakness is a buying opportunity given 18% FY27–29E EBITDA CAGR and attractive 24x FY28E EV/EBITDA.

 07 Sep 2026 08:51 AM

Fortis Healthcare: Jefferies on Fortis Healthcare Buy, Target Price ₹1,125, as the forensic audit is unlikely to disrupt operations or expansion, IHH remains committed to Fortis as its India growth platform, and any audit-led weakness is a buying opportunity given 18% FY27–29E EBITDA CAGR and attractive 24x FY28E EV/EBITDA.

Fortis Healthcare: Nomura on Fortis Healthcare Neutral, Target Price ₹1,030, as the forensic audit into the ₹46.7bn RHT-IHH transaction is investigative and operations/growth plans remain insulated, while IHH’s commitment to raise its stake to 51% and eventually merge Gleneagles India with Fortis broadly aligns with Street expectations.

 07 Sep 2026 08:51 AM

Fortis Healthcare: Nomura on Fortis Healthcare Neutral, Target Price ₹1,030, as the forensic audit into the ₹46.7bn RHT-IHH transaction is investigative and operations/growth plans remain insulated, while IHH’s commitment to raise its stake to 51% and eventually merge Gleneagles India with Fortis broadly aligns with Street expectations.

Fortis Healthcare: Co May Move Supreme Court Against Delhi HC Order In Daiichi Arbitration Case - Newspaper

 02 Sep 2026 09:12 AM

Fortis Healthcare: Co May Move Supreme Court Against Delhi HC Order In Daiichi Arbitration Case - Newspaper

Fortis Healthcare: Will Hold Meeting With Analysts And Investors On September 4 At 1 PM.

 01 Sep 2026 07:58 PM

Fortis Healthcare: Will Hold Meeting With Analysts And Investors On September 4 At 1 PM.

Fortis Healthcare: Forensic Audit Ordered By Delhi HC In Daiichi Case; No Liability Or Penalties Imposed

 01 Sep 2026 07:33 AM

Fortis Healthcare: Forensic Audit Ordered By Delhi HC In Daiichi Case; No Liability Or Penalties Imposed

Fortis: High Court Appoints Forensic Auditor To Investigate Fortis Religare Deal. Sankyo Requested Audit In Fortis Case.

 31 Aug 2026 10:56 AM

Fortis: High Court Appoints Forensic Auditor To Investigate Fortis Religare Deal. Sankyo Requested Audit In Fortis Case.

Fortis Healthcare: IHH Plans To Raise Its Stake In Co From 31% To 51%

 28 Aug 2026 10:09 AM

Fortis Healthcare: IHH Plans To Raise Its Stake In Co From 31% To 51%

Fortis Healthcare: Citi on Fortis Healthcare Maintains Buy with Target Price of ₹1,180 as hospital margin recovery, new bed additions, 19% hospital revenue growth and management’s 25% EBITDA margin target by FY28 support accelerating earnings growth.

 19 Aug 2026 09:08 AM

Fortis Healthcare: Citi on Fortis Healthcare Maintains Buy with Target Price of ₹1,180 as hospital margin recovery, new bed additions, 19% hospital revenue growth and management’s 25% EBITDA margin target by FY28 support accelerating earnings growth.

Fortis Healthcare: Guidance - Management maintains its consolidated EBITDA margin guidance for FY27, expecting to achieve 25% EBITDA margin by FY28, inclusive of ESOP costs, which will be offset by operational improvements.- Concall Update

 10 Aug 2026 09:05 AM

Fortis Healthcare: Guidance - Management maintains its consolidated EBITDA margin guidance for FY27, expecting to achieve 25% EBITDA margin by FY28, inclusive of ESOP costs, which will be offset by operational improvements.- Concall Update